Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
Drug Demand
5-year high
|
Strong Performer, Getting Expensive
1454.2000
-26.80
(
-1.81
%)
NSE
Jun 24, 2026
15:31 PM
New 52W High today
Volume:
2.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
05 Dec 2016
Drug Demand
5-year high
1454.20
-1.81%
IPO Note - Laurus Labs Ltd
ipo note:
Laurus Labs Ltd.
by
Aditya Birla Money Limited
Aditya Birla Money Limited
Laurus Labs has gained
34.05%
in the last 6 Months
More from Laurus Labs Ltd.
All Rapid Results
Recommended
Market closes higher, led by realty and private bank stocks
Trendlyne Marketwatch |
24 Jun 2026, 04:00PM
Five stocks to buy from analysts this week - June 23, 2026
The Baseline |
23 Jun 2026, 06:10PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020